Macrorecombination in isolated cell pairs via natural genetic transformation

通过自然遗传转化在分离的细胞对中进行宏重组

• 批准号: 10609526
• 负责人: David Eddington
• 金额: $ 58.32万
• 依托单位: UNIVERSITY OF ILLINOIS AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-05-21 至 2026-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10609526
• 关键词: Affect; Antibiotic Resistance; Antibiotic Therapy; Antibiotics; Bacteria; Base Pairing; Cell Communication; Cell Separation; Cells; Cessation of life; Clinical; Complex; Cytolysis; DNA; Dangerousness; Development; Devices; Diameter; Disease; Effectiveness; Event; Failure; Gene Exchanges; Gene Transfer; Generations; Genes; Genetic; Genetic Recombination; Genetic Transformation; Genome; Genomic Segment; Genomics; Gram-Positive Bacteria; Horizontal Gene Transfer; Immune; In Vitro; Individual; Infection; Intelligence; Intervention; Laboratories; Lytic; Maps; Measures; Mediating; Medical; Meningitis; Microbial Biofilms; Microfluidic Microchips; Microfluidics; Modeling; Molecular; Names; Nucleotides; Participant; Pathogenicity; Patients; Pattern; Peptides; Pneumonia; Population; Process; Property; Reporting; Resolution; Sepsis; Serotyping; Streptococcus; Streptococcus pneumoniae; System; Time; Vaccination; Vaccines; Virulence Factors; Visual; Visualization; Work; aqueous; bactericide; cell transformation; combat; flexibility; genome sequencing; genome-wide; human pathogen; meter; model organism; novel therapeutics; pathogen; pathogenic bacteria; prophylactic; resistance gene; resistant strain; success; tool; uptake; vaccine formulation; whole genome

Abstract /Summary: Streptococcus pneumoniae (pneumococcus) is a major global bacterial human pathogen, causing ~1 million deaths annually worldwide, due to pneumonia, sepsis, and meningitis. Two strategies are used to combat such infections. Antibiotics can often cure such infections, and vaccines are used to reduce the circulating populations of the most dangerous serotypes. However, both strategies are failing at an increasing rate. Antibiotic resistant strains are continually arising and spreading globally; vaccination effectiveness is also under challenge, as serotypes not targeted by current vaccine formulations are continually arising and rapidly replacing the targeted ones. The cause of these failures is transfer of multiple foreign genes into the bacteria, but the mechanisms that create the new infectious and resistant strain types are unclear. Transfer events are of two types, named as micro- and macro-recombination events. The micro events, involving dozens to several thousands of base pairs, are consistent with the known properties of gene transfer by transformation in pneumococcus. However, more significant events involve transfer of multiple blocks of tens of thousands of nucleotides, sometimes all from a single donor strain. These macro-recombination events were difficult to reconcile completely with any known mechanism of gene transfer - whether conjugation, transduction, or transformation. This project would use microfluidics to create numerous small chambers (droplets) within which attacker- target interactions can be studied and characterized for the first time at both the cellular and molecular levels, both by identifying the participant cells and by tracing all gene exchange events at full genome scale and 200-bp resolution. Medical Relevance. Most pathogenic streptococci share the mechanism of gene transfer by natural genetic transformation. Genetic transformation is an important path for genetic flexibility in pneumococcus, where it is documented as key to vaccine escape and creation and spread of new drug-resistance genes. Because Streptococcus pneumoniae is a model organism for the study of DNA uptake, this work on the mechanism that transfers unexpectedly large blocks of genes between strains or species will have broad impacts on understanding and targeting the many similar peptide regulated gene exchange systems among Gram positive bacteria that are often associated with the ability of these bacteria to cause disease.

摘要/总结： 肺炎链球菌（肺炎球菌）是一种主要的全球性细菌性人类病原体，引起 全世界每年约有100万人死于肺炎、败血症和脑膜炎。两种策略 是用来对抗这种感染的。抗生素通常可以治愈这种感染，疫苗也是如此。 用于减少最危险血清型的流通人群。但无论 战略正在以越来越快的速度失败。抗生素耐药菌株不断出现， 在全球范围内蔓延;疫苗接种的有效性也受到挑战，因为血清型没有针对性 目前的疫苗制剂不断出现并迅速取代靶向制剂。 这些失败的原因是多个外源基因转移到细菌中，但 产生新的感染性和耐药性菌株类型的机制尚不清楚。转移事件 有两种类型，称为微观和宏观重组事件。微事件，包括 几十到几千个碱基对，与基因的已知特性一致， 在肺炎球菌中通过转化而转移。然而，更重要的事件涉及转移 数万个核苷酸的多个区块，有时全部来自单个供体菌株。 这些宏观重组事件很难与任何已知的 基因转移的机制-无论是接合、转导还是转化。这个项目 将使用微流体技术来创建许多小腔室（液滴），其中攻击者- 靶相互作用可以研究和表征的第一次在两个细胞和 分子水平，通过识别参与细胞和追踪所有基因交换事件 在全基因组规模和200-bp分辨率下。 医学相关性。大多数致病性链球菌都有基因转移的机制， 自然的基因转化。遗传转化是实现遗传柔性的重要途径 在肺炎球菌中，它被记录为疫苗逃逸以及产生和传播 新的耐药基因由于肺炎链球菌是肺炎链球菌的模式生物， DNA摄取的研究，这项工作的机制，转移意外大块的 菌株或物种之间的基因将对理解和靶向 革兰氏阳性菌中许多类似的肽调节基因交换系统， 通常与这些细菌引起疾病的能力有关。